Mitochondrial dysfunction in type 2 diabetes

W. Groenendaal, R.G.P.M. Stiphout, van, P.J. Verhoog, J.A.L. Jeneson, N.A.W. Riel, van, P.A.J. Hilbers

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review


Type 2 diabetes is a degenerative disease afflicting modern Western society. Recently, an association was found between mitochondrial function and development of the disease. Abnormal mitochondrial function may, on the one hand, result in a failing cellular energy supply and, on the other, in elevated oxidative stress. Downstream effects of the latter are typically detrimental, impacting cell function both on a microscopic (i.e., damage to proteins and lipids of individual mitochondria and other cell constituents) as well as macroscopic scale (e.g., spatial reorganization of the cellular mitochondrial network).This research project seeks to gain insight into the development of type 2 diabetes by investigating how impaired mitochondrial function impacts cell function on both the microscopic as well as macroscopic scale. Hereto, a systems biology approach, combining computational modeling on the one hand, and low-to-medium throughput quantitative and dynamic measurements on the other, will be applied. All investigations will be conducted in skeletal muscle, one of the main affected tissues in diabetes type 2.The model of Van Stiphout et al 2006 will be adapted and used to test different hypotheses for the development of type 2 diabetes. The alterations will include the addition of the sarcoplasmatic reticulum, radical production in the mitochondrion and possible reduction of the model based on a sensitivity analysis and the results of Van Stiphout et al.
Original languageEnglish
Title of host publicationProceedings of the 2nd FEBS Advanced Lecture Course on Systems Biology - from Molecules to Life (FEBS-SysBio2007), 10-16 March 2007, Gosau, Austria
Place of PublicationAustria, Gosau
Publication statusPublished - 2007


Dive into the research topics of 'Mitochondrial dysfunction in type 2 diabetes'. Together they form a unique fingerprint.

Cite this